Article: EFFICACY AND CLINICAL SAFETY OF PRISHIPARNI GHANAVATI IN GESTATIONAL DIABETES MELLITUS (PRAMEHA IN GARBHINI)

Article Category: Original Research articles

DOI: 10.7897/2277-4343.130489

Pages: 62-65

Author: Namrata Bhausaheb Khose, Swati Mohite *

Abstract: Aim: To study the efficacy and clinical safety of Prishniparni ghanavati in Gestational Diabetes Mellitus (Prameha in Garbhini). Methodology: The study was conducted on 20 patients, Prishniparni ghanavati 500 mg twice daily, with warm water. This study was conducted at Bharati Ayurveda hospital during 2020-2022. It was a randomized, open-control trial study. Patients with raised DIPSI (Diabetes in pregnancy societies of India), i.e., above 140 mg/dl and below 200 mg/dl, were included in this study. Results: A total of 31 patients were evaluated in this study. Out of which, 30 were recruited and 20 patients completed. A total of two patients dropped out due to factors like the covid-19 pandemic, irregular follow-up, etc. The herbal medicine was tolerated well in trial group patients. Conclusions: In this study, it is proved that prishniparni could be the choice of the herb in these cases. Prishniparni proved effective in managing GDM if the BSL is less than 200. All patients well tolerated the herb. The side effects are not observed in this study.

Keyword: Prameha in Garbhini, Gestational Diabetes Mellitus